Effects of telmisartan vs olmesartan on metabolic parameters, insulin resistance and adipocytokines in hypertensive obese patients

Nutricion Hospitalaria

Volumn 25, Issue 2, 2010, Pages 275-279

  De Luis, D A ^a   Conde, R ^a   Gonzalez Sagrado M ^a   Aller, R ^a   Izaola, O ^a   Duenas A ^a   Perez Castrillon J L ^a   Romero, E ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Adiponectin; Hypertension; Insulin resistance; Leptin; Olmesartan; Telmisartan

Indexed keywords

ADIPOCYTOKINE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; CHOLESTEROL; IMIDAZOLE DERIVATIVE; OLMESARTAN; TELMISARTAN; TETRAZOLE DERIVATIVE; TRIACYLGLYCEROL;

ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADIPOKINES; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; BENZOATES; CHOLESTEROL; FEMALE; HUMANS; HYPERTENSION; IMIDAZOLES; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; TETRAZOLES; TRIGLYCERIDES;

EID: 77950315221     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2010.25.2.4545     Document Type: Article

References (29)

1. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 911-919
2. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin. Clin Chemistry 2004;50: 1511-1525
3. De Luis DA, M Gonzalez Sagrado, R Conde, R Aller, O Izaola. Circulating adipocytokines in obese non diabetic patients, relation with cardiovascular risk factors, anthropometry and resting energy expenditure. Ann Nutr Metab 2007; 51: 374-378
4. Matsuda M, Shimomura I, Sata M. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002; 277: 37487-37491
5. Kumada M, Kihara S, Sumitsuji S. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23: 85-89
6. Shimomoura I, Hammer RE, Ikemoto S. Leptin reverses insulin resitance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999; 401: 73-76
7. Hirose H, Saito I, Kawabe H, Satura T. Insulin resistance and hypertension: seven year follow up study in middle-aged Japanese men (the KEIO study). Hypertens Res 2003; 26: 780-795
8. Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G et al. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 2003; 35: 807-825
9. Skurk T, Van Harmelen V, Haumer H. Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from culturesd human adipocytes by activation of NF-kB. Arterioscler Thromb Vasc Biol 2004; 24: 1199-1203
10. Cassis LA, English VL, Bharadwaj K, Boustany CM. Differential effects of local versus systemic angiotensin II in the regulation of leptin release from adipocytes. Endocrinology 2004; 145: 169-174
11. Hattori Y, Akimoto K, Gross SS, Hattori S, Kasai K. Angiotensin II induced oxidative stress elicits hypoadiponectinemia in rats. Diabetologia 2005; 48: 1066-1074
12. Jandeleit-Dahm KA, Tikellis C, Reid CM, Johston CI, Cooper ME. Why blockade of rennin-angiotensin system reduces the incidence of new-onset diabetes. J Hypertens 2005; 23: 463-473
13. World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 151-183
14. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher Df. Homesotasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-414
15. Katz A, Nambi SS, Mather K. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivityin humans. J Clin Endocrinol Metab2000; 85: 2402-2405
16. Furuhashi M, Ura N, Takizawa H, Yoshida D, Moniwa N, Murakami H et al. Blockade of the rennin-angiotensin system decrease adipocyte size with improvement in insulin sensitivity. J Hypertens 2004; 22: 1977-1982
17. Furuya R, Odamaki M, Kugamai H, Hishida A. Impact of angiotensin II receptor blocker on plasma levels of adiponectin and advanced oxidation protein products in peritoneal dialysis patients. Blood Purif 2006; 24: 445-450
18. Yenicesu M, Yilmaz MI, Caglar K, Sonmez A, Eyleten T, Acikel C, Kilic S, Bingol N et al. Blockade of the rennin-angiotensin system increases plasma adiponectin levels in type-2 patients with proteinuria. Nephron Clin Pract 2005; 99: c115-c121.
19. Benson C, Perdhadsingh HA, Ho CI. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma modulating activity. Hypertension 2004; 43: 993-1002.
20. Kodama J, Katayama S, Tanaka K, Itabashi A, Kawazu S, Ishii J. Effect of captoprol on glucose concentration. Possible role of augmented postprandial forearm blood flow. Diabetes Care 1999; 13: 1101-1111
21. Folli F, Saad MJ, Velloso L. Crosstalk between insulin and angiotensin II signaling systems. Exp CLin Endocrinol Diabetes 1999; 107: 133-139
22. Togashi N, Ura N, Higashiura K, Murakami H, Simamoto K. The contribution of skeletal muscle tumor necrosis factor to insulin resistance and hypertension in fructose fed rats. J Hypertens 2000; 18: 1605-1610
23. Higashiura K, Ura N, Takada T. The effect of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonists on insulin resistance in fructose-fed rats. Am J Hypertens 2000; 13: 290-297
24. Negro R, Formoso G, Hassan H. The effects of irbesartan and telmisartan on metabolic parameters and blood pressure in obese, insulin resistant, hypertensive patients. J Endocrinol Invest 2006; 957-961
25. Bogan JS, Lodish HF. Two compaments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endocgenous ACRP30 and GLUT4. J Cell Biol 1999: 146: 609-620
26. Cases JA, Gabrielly I, Ma XH. Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo. Diabetes 2001; 50: 348-352
27. Schschols AM, Creutzberg EC, Buurman WA. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1220-1226
28. Hollenberg AN, Susulic VS, Madura JP, Zhang B, Moller DE. Tontonoz P et al. Functional anyagonism between CCAAT/enhancer binding protein-alpha and peroxisome proliferators-activated receptor-gamma on the leptin promoter. J Biol Chem 1997; 272: 5283-5290
29. Ran J, Hirano T, Adach M. AngiotensinII type 1 receptor blocker ameliorates overprocution and accumulation of triglycerides in the liver of the Zucker fatty rats. Am J Physiol Endo-crinol Metab 2004; 287: 227-232